Matrix Metalloproteinase 2 Immunoreactive Protein Appears Early in Cervical Epithelial Dedifferentiation
- 31 March 1999
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 72 (3), 306-311
- https://doi.org/10.1006/gyno.1998.5157
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Microinvasive Cervical Carcinoma and Cervical Intraepithelial Neoplasia: Biologic Significance and Clinical Implications of 72-kDa Metalloproteinase ImmunostainingGynecologic Oncology, 1996
- The 72-kDa Metalloproteinase Immunostaining in Cervical Carcinoma: Relationship with Lymph Nodal InvolvementGynecologic Oncology, 1996
- Modulation of Mr 72,000 and Mr 92,000 type-IV collagenase (gelatinase A and B) gene expression by interferons alpha and gamma in human melanomaInternational Journal of Cancer, 1994
- Pap smear screening and changes in cervical cancer mortality in SwedenInternational Journal of Gynecology & Obstetrics, 1994
- Immunohistochemical localization of matrix metallloproteinase 2 and its specific inhibitor timp‐2 in neoplastic tissues with monclonal antibodiesInternational Journal of Cancer, 1994
- Evaluation of Basement Membrane Components and the 72 kDa Type IV Collagenase in Serous Tumors of the OvaryThe American Journal of Surgical Pathology, 1992
- Recombinant interferon alpha and gamma modulate the invasive potential of human melanoma in vitroInternational Journal of Cancer, 1991
- Modulation of type‐iv collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type‐iv collagenaseInternational Journal of Cancer, 1990
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- Metastatic potential correlates with enzymatic degradation of basement membrane collagenNature, 1980